• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧托溴铵(Ba 253),抗胆碱能支气管扩张治疗领域的一项进展。初步结果。

Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.

作者信息

Minette A, Marcq M

出版信息

Rev Inst Hyg Mines (Hasselt). 1979;34(3):115-23.

PMID:45210
Abstract

The changes in FEV1 and in specific conductance induced by 200 micrograms oxitropium bromide given as pressurized aerosol were measured at 8 time intervals during 7 hours after inhalation in a group of 19 patients with reversible broncho-obstruction. The working of the drug was compared to the functional values observed at the same time intervals after placebo, 40 micrograms ipratropium bromide and 400 micrograms fenoterol. Both oxitropium and ipratropium were definitely and significantly superior to placebo at all time intervals. Oxitropium was superior to ipratropium at the 7th hour. At this time interval the difference was significant At the 7th hour oxitropium gave higher mean results than fenoterol, but this difference was not significant. The drug was also compared to its competitors regarding its subjective and cardiovascular tolerance. No unfavourable side-effects were observed.

摘要

在一组19例可逆性支气管阻塞患者中,于吸入200微克溴化氧托品(以压力定量气雾剂给药)后的7小时内,每隔一定时间间隔测量1秒用力呼气容积(FEV1)和比气道传导率的变化。将该药的作用与安慰剂、40微克异丙托溴铵和400微克非诺特罗在相同时间间隔后观察到的功能值进行比较。在所有时间间隔,氧托品和异丙托溴铵均明显且显著优于安慰剂。在第7小时,氧托品优于异丙托溴铵。在此时间间隔,差异具有显著性。在第7小时,氧托品的平均结果高于非诺特罗,但这种差异不具有显著性。还就该药的主观耐受性和心血管耐受性与其他同类药物进行了比较。未观察到不良副作用。

相似文献

1
Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.氧托溴铵(Ba 253),抗胆碱能支气管扩张治疗领域的一项进展。初步结果。
Rev Inst Hyg Mines (Hasselt). 1979;34(3):115-23.
2
A comparison of oxitropium bromide and ipratropium bromide in asthma.
Eur J Respir Dis. 1984 Feb;65(2):106-8.
3
Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.使用定量吸入器对慢性阻塞性肺疾病患者进行三种抗胆碱能药物与非诺特罗的比较剂量反应研究。
Thorax. 1995 Jan;50(1):62-6. doi: 10.1136/thx.50.1.62.
4
Oxitropium bromide: an acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis.氧托溴铵:一种新型抗胆碱能药物与非诺特罗联合用于哮喘和慢性支气管炎的急性剂量反应研究。
Pulm Pharmacol. 1990;3(2):55-8. doi: 10.1016/0952-0600(90)90032-e.
5
Oxitropium bromide, ipratropium bromide and fenoterol in exercise-induced asthma.氧托溴铵、异丙托溴铵与非诺特罗治疗运动诱发性哮喘
Respiration. 1982;43(1):57-63. doi: 10.1159/000194464.
6
Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.氧托溴铵。一种新型抗胆碱能支气管扩张剂的剂量反应和时间反应研究。
Chest. 1986 Feb;89(2):249-53. doi: 10.1378/chest.89.2.249.
7
Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack.
J Asthma. 1999;36(1):67-75. doi: 10.3109/02770909909065151.
8
[Treatment of bronchial obstruction with beta-2-mimetic and anticholinergic agents in aerosol. Advantages of the combination of both groups of pharmaceuticals].
Rev Inst Hyg Mines (Hasselt). 1980;35(2):85-114.
9
Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.抗胆碱能药物对哮喘患者中乙酰甲胆碱诱导的支气管收缩的保护作用比较。
J Asthma. 2008 Jun;45(5):397-401. doi: 10.1080/02770900801971818.
10
Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients.
Del Med J. 1994 Oct;66(10):549-52.

引用本文的文献

1
Anticholinergic agents for chronic asthma in adults.用于成人慢性哮喘的抗胆碱能药物。
Cochrane Database Syst Rev. 2004;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2.
2
Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.长效β2受体激动剂在稳定期慢性阻塞性肺疾病管理中的应用
Drugs. 2000 Aug;60(2):307-20. doi: 10.2165/00003495-200060020-00005.
3
Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
Clin Auton Res. 1993 Feb;3(1):41-4. doi: 10.1007/BF01819142.
4
Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
Clin Auton Res. 1993 Feb;3(1):31-5. doi: 10.1007/BF01819140.